查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095201

菸鹼醯胺市場－2026-2032年全球市場預測

Niacinamide Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，菸鹼醯胺市場規模將達到 11.9026 億美元，複合年成長率為 6.17%。

主要市場統計數據
基準年 2025 7.8266億美元
預計年份：2026年 8.2602億美元
預測年份 2032 1,190,260,000 美元
複合年成長率 (%) 6.17%

菸鹼醯胺執行摘要：護膚、營養與健康領域實證成長

菸鹼醯胺（也稱為尼克醯胺或維生素B3醯胺）是皮膚病學、個人護理、營養保健品、藥品和動物營養領域中一種具有策略意義的重要成分。其重要性已獲得可靠的科學證據支持。菸鹼醯胺易溶於水，在典型產品條件下具有良好的配方穩定性，並因其透過NAD+和NADP+途徑參與細胞能量代謝而備受認可。在護膚，同行評審的研究表明，外用菸鹼醯胺可以增強皮膚屏障功能，改善膚色不均，減少可見的泛紅，調節皮脂分泌，並提高皮膚對多成分配方的耐受性。在營養和保健領域，菸鹼醯胺用於幫助維持充足的維生素B3攝入，同時避免通常與菸鹼酸相關的潮紅反應。消費者對具有科學依據的活性成分、受皮膚科醫生影響的護膚習慣、預防性健康、潔淨標示定位以及多功能配方的需求，共同推動了市場對煙醯胺的需求。同時，製造商正積極應對消費者對成分可追溯性、品質一致性、監管文件和負責任採購日益成長的期望。競爭格局正日益有利於那些能夠兼顧經證實的功效、符合監管規定的功效聲明、配方兼容性以及透明供應鏈的供應商和配方開發商。菸鹼醯胺市場正經歷著變革性的轉變。

人工智慧對菸鹼醯胺創新產生的累積影響

人工智慧 (AI) 正在加速菸鹼醯胺價值鏈的發展，它能夠改善配方設計、品管、法規資訊和需求預測，同時又不取代經過檢驗的實驗室數據和臨床證據。在產品開發方面，AI 模型篩檢成分組合、預測穩定性風險並評估質地，從而幫助最佳化菸鹼醯胺濃度，以適應特定市場定位，例如敏感肌膚、痤瘡護理、美白、屏障功能修復或保健品。在生產製造方面，機器學習可以輔助進行製程監控、批次間一致性檢測、雜質檢測和偏差分析，幫助製造商維持化妝品、食品、藥品和飼料菸鹼醯胺產品更嚴格的品質標準。在法規和標籤管理方面，AI 工具可用於監控各司法管轄區成分法規、標籤要求、可接受的標籤內容和安全文件的變更。在商業應用方面，自然語言處理和社交媒體聆聽有助於識別消費者關注的新問題，例如皮膚屏障損傷、色素沉著、痤瘡肌膚的護膚流程以及成分精簡主義。然而，人工智慧產生的資訊必須受到嚴格的資料品質標準、專家科學審查、網路安全措施和書面檢驗協議的約束。人工智慧最有價值的優勢在於其能夠縮短研發週期、減少配方返工，並增強菸鹼醯胺所有應用領域中基於證據的決策。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區擁有大規模的個人照護、營養補充品、製藥和動物營養產業，是菸鹼醯胺消費和生產的主要中心。中國和印度尤其重要，這得益於其強大的化學品製造能力、不斷壯大的中產階級消費群體以及對價格適中的功能性成分的需求。日本、韓國和澳洲則專注於高品質的化妝品配方、嚴格的監管以及皮膚健康領域的創新。北美地區對皮膚科醫生推薦的護膚品、營養補充劑、強化食品和循證健康產品的需求強勁，尤其在美國和加拿大，消費者高度重視循證功效聲明、成分安全性和透明的標籤。拉丁美洲地區的重要性日益凸顯，這得益於美容和個人保健產品消費量的成長、藥店零售網路的滲透以及食品強化措施的推進，其中巴西和墨西哥是護膚、護髮產品和營養補充劑的主要需求中心。歐洲擁有高度監管的環境，化妝品成分安全評估、永續性標準和負責任的功效聲明在菸鹼醯胺的商業化過程中發揮核心作用。此外，消費者對多功能且親膚配方產品的偏好，也推動了臉部保養和身體保養產品的持續應用。中東地區的特點是高階美容產品蓬勃發展，消費者對日曬相關的護膚需求旺盛，並且需要符合皮膚病學指南的產品。同時，非洲市場蘊藏長期發展機遇，這得益於營養狀況的改善、藥房的普及、個人護理市場的不斷成長以及本地化的分銷策略。在所有地區，監管合規、品質文件齊全以及針對特定應用的技術支援仍然是市場准入的關鍵因素。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約成員國的關鍵群體洞察

在東協市場，隨著都市區消費者越來越重視以科學為基礎的護膚流程、符合清真標準的配方以及透過藥局、現代零售通路和數位管道購買的美容產品，菸鹼醯胺的重要性日益凸顯。在海灣合作理事會（GCC）國家，消費者對高階個人保健產品、皮膚科研發產品以及防曬油護膚流程表現出濃厚的興趣，這使得煙醯胺成為改善膚色不均、修復皮膚屏障功能以及提昇在炎熱潮濕氣候下妝容持久度的理想成分。歐盟仍然是對含有菸鹼醯胺的化妝品、食品和保健品法規環境之一，其在安全評估、標籤、產品資訊文件以及基於證據的功效聲明等方面的合規要求，對該地區生產商和出口商都產生了影響。金磚國家（BRICS）的需求促進因素則呈現多元化的特徵。中國和印度正在擴大生產和消費規模，巴西正在提升美容和個人保健產品的市場滲透率，俄羅斯在醫藥和營養領域保持著強勁的需求，而南非則是非洲分銷的門戶。在七國集團（G7）國家，優質化、臨床定位、成分透明度和高生產標準普遍受到重視，這為差異化菸鹼醯胺等級和經證實的功效創造了機會。北約成員國與北美和歐洲先進的監管和品質系統高度重合，在這些地區，供應鏈韌性、雙重採購和文件可靠性正日益成為重要的採購考量。在這些國家，成功的關鍵在於根據當地的法律規範、購買力、消費者教育程度和產品形態偏好來調整菸鹼醯胺的市場定位。

來自主要國家關於菸鹼醯胺的傳播和商業策略的見解

美國是菸鹼醯胺的主要需求市場，其產品涵蓋皮膚科醫生推薦的護膚、祛痘產品、屏障護理產品、膳食補充劑和營養強化型健康產品。這得歸功於消費者對菸鹼醯胺的高度認知和廣泛的零售管道。加拿大也呈現類似的需求模式，但更注重雙語標籤、安全文件以及藥屋主導的皮膚健康產品類別。在墨西哥，美容消費的成長與個人保健產品和膳食補充劑獲取管道的增加相輔相成；而巴西則以其成熟的化妝品文化、廣泛的身體保養以及對適用於不同氣候和皮膚問題的多功能活性成分的關注而脫穎而出。英國在成分認知、臨床護膚資訊傳播和線上美容零售方面持續發揮重要作用；德國則強調產品品質、耐受性、永續性和藥房推薦配方。在法國，皮膚化妝品的信譽度與對高階護膚的需求相結合；而在義大利和西班牙，受地中海護膚習慣的影響，菸鹼醯胺在美容、防曬油和個人護理產品類別中的應用日益廣泛。儘管貿易和供應狀況有所變化，俄羅斯在醫藥、保健品和個人護理領域的需求仍然強勁。中國是菸鹼醯胺的核心市場，主導的製造地電子商務為主導的美容生態系統以及消費者對美白和肌膚問題護理配方的濃厚興趣。在印度，市場正透過醫藥、營養保健品、價格親民的護膚品以及大規模的年輕消費族群不斷擴張。同時，日本市場則專注於高純度、親膚且技術先進的配方。在澳大利亞，菸鹼醯胺因其在日曬後肌膚護膚和相關健康管道中的應用而備受青睞。韓國則透過韓妝潮流、多層次護膚流程以及活性成分宣傳活動，持續影響全球產品創新。在這些國家，確保配方功效聲明符合當地法規和消費者預期至關重要。

為菸鹼醯胺產業的領導者提供的實用建議

產業領導企業應優先考慮基於證據的差異化，將菸鹼醯胺的等級、濃度和產品形式與具體且經證實的功效聯繫起來，例如增強皮膚屏障功能、顯著改善膚色、控制皮脂分泌、提供充足的營養以及促進新陳代謝。配方研發人員應投資於穩定性測試、相容性篩檢和感官特性最佳化，尤其是將菸鹼醯胺與類視色素A、酸、胜肽​​、鋅鹽、神經醯胺、防曬油劑或植物萃取物結合時。供應商應透過雜質分析、可追溯性文件、批間一致性以及針對化妝品、食品、藥品和飼料應用的可審核監管文件來加強其品管系統。品牌應避免誇大其詞，而是製定符合監管規定且針對特定地區的通訊，並以臨床、儀器或文獻證據為支撐。採購團隊應透過合格多個供應商、監測地緣政治和物流中斷以及評估永續績效來降低供應風險。數位團隊應利用人工智慧驅動的消費者洞察來識別尚未滿足的需求，而科學和監管團隊則必須在做出任何聲明之前檢驗這些發現。高階品類的公司應優先考慮透明度、皮膚適用性、與皮膚科醫生合作以及針對所有膚質的全面測試，而注重性價比的公司則應優先考慮價格、功效和易於理解的信息。最有效的策略是將技術檢驗、監管準備、負責任的採購和清晰的消費者溝通融為一體。

基於證據的菸鹼醯胺分析的調查方法

本執行摘要基於系統性的二手研究途徑，採用檢驗的科學、監管和產業相關資訊來源。調查方法包括對同行評審的皮膚病學、營養學、藥學和化妝品科學文獻進行回顧，這些文獻涵蓋菸鹼醯胺的安全性、功效、製劑特性和生物學功能。監管分析參考了主要司法管轄區內權威機構發布的關於化妝品、膳食補充劑、藥品、食品強化、化學品安全和動物飼料的公開指南和框架。貿易和行業解讀基於已記錄的應用趨勢、成分使用模式、產品定位、供應鏈考慮和區域監管要求。研究結果透過交叉檢驗進行整合，以確保資訊來源的可靠性、證據的一致性以及與商業性決策的相關性。本分析未採用市場規模、市佔率或預測假設。本分析著重於資料支援的定性見解，包括應用趨勢、區域擴散因素、技術影響、合規性考量以及對整個菸鹼醯胺價值鏈相關人員的策略意義。

結論：菸鹼醯胺仍然是科學主導產品創新中的一種策略性成分。

菸鹼醯胺是一種用途廣泛的成分，擁有可靠的科學依據，可與多種配方相容，並適用於美容、健康、製藥和營養等領域。在消費者和專業人士要求產品具備多功能性、耐受性以及明確功效證據支持的領域，菸鹼醯胺的吸引力尤其突出。區域趨勢表明，亞太地區擁有強大的生產基地和創新動力；北美和歐洲對功效聲明和品質有著很高的標準；拉丁美洲和中東的美容和健康領域對煙醯胺的需求日益成長；非洲則在營養和個人護理領域展現出新的機遇。人工智慧透過加快研發速度、確保品質穩定、加強檢驗以及提供消費者洞察，為菸鹼醯胺增添了價值，但經過驗證的科學證據和合規的文件仍然至關重要。對於行業相關人員而言，長期成功的關鍵在於將高品質的煙鹼醯胺原料採購、針對特定應用的功效支持、負責任的功效聲明以及穩健的供應鏈相結合。隨著原料透明度和基於科學的採購決策變得越來越重要，菸鹼醯胺仍然是尋求可靠和多功能解決方案的製造商和品牌的核心活性成分。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 菸鹼醯胺市場：依形式分類

  • 膠囊
  • 液體
  • 粉末
  • 藥片
  • 顆粒

第8章：菸鹼醯胺市場：依來源分類

  • 天然來源
    • 植物來源
    • 發酵衍生的
  • 合成

第9章：菸鹼醯胺市場：依純度分類

  • 低於98%
  • 98％～99％
  • 超過99%

第10章：菸鹼醯胺市場：依包裝類型分類

  • 瓶子
  • 小袋
  • 管子
  • 小袋

第11章 菸鹼醯胺市場：依應用領域分類

  • 動物飼料
    • 水產飼料
    • 家禽飼料
    • 豬飼料
  • 化妝品和個人護理
    • 彩妝
    • 護髮
      • 洗髮精
      • 護髮素
    • 護膚
      • 血清
      • 奶油
      • 洗劑
      • 口罩
      • 防曬油
  • 營養保健品和膳食補充劑
  • 食品/飲料
    • 烘焙產品
    • 運動營養
    • 乳製品
  • 製藥
    • 皮膚科藥物
    • 維生素缺乏症的治療
    • 糖尿病管理

第12章 菸鹼醯胺市場：依分銷通路分類

  • 線上
    • 企業網站
    • 電子商務平台
  • 離線
    • 藥局/藥局
    • 專賣店
    • 超級市場和大賣場

第13章 菸鹼醯胺市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 菸鹼醯胺市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 菸鹼醯胺市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aarti Drugs Limited
  • Anhui Redpont Biotechnology Co., Ltd.
  • Brother Enterprises Holding Co., Ltd.
  • Crevil Cosmetics & Pharmaceuticals Germany GmbH
  • CSPC Pharmaceutical Group Limited
  • Evonik Industries AG
  • Fagron NV
  • Fengchen Group Co.,Ltd
  • Foodchem International Corporation
  • Glanbia Nutritionals, Inc.
  • HCP Wellness
  • Jubilant Ingrevia Limited
  • Koninklijke DSM NV
  • Lasons India Private Limited
  • Lonza Group AG
  • Merck KGaA
  • Nutraceutical Corporation
  • Prinova Group LLC
  • Shandong Hongda Biotechnology Co., Ltd.
  • Suzhou Springchem International Co., Ltd.
  • Swadesh India Chemical Pvt Ltd
  • Tianjin Zhongrui Pharmaceutical Co., Ltd.
  • Triveni Interchem Pvt Ltd
  • Western Drugs Ltd
  • Zancheng Life Sciences Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market is projected to grow by USD 1,190.26 million at a CAGR of 6.17% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 782.66 million
Estimated Year [2026] USD 826.02 million
Forecast Year [2032] USD 1,190.26 million
CAGR (%) 6.17%

Niacinamide Executive Summary: Science-Backed Growth Across Skin Care, Nutrition, and Health Applications

Niacinamide, also known as nicotinamide or vitamin B3 amide, is a strategically important ingredient across dermatology, personal care, nutraceuticals, pharmaceuticals, and animal nutrition. Its relevance is supported by a robust scientific profile: niacinamide is water-soluble, formulation-stable under common product conditions, and recognized for its role in cellular energy metabolism through NAD+ and NADP+ pathways. In skin care, peer-reviewed evidence links topical niacinamide with barrier support, improved appearance of uneven tone, reduced visible redness, sebum regulation, and enhanced tolerance in multi-ingredient formulations. In nutrition and healthcare, niacinamide is used to support vitamin B3 adequacy while avoiding the flushing commonly associated with nicotinic acid. Demand is being shaped by consumer interest in science-backed active ingredients, dermatologist-influenced routines, preventive wellness, clean-label positioning, and multifunctional formulations. At the same time, manufacturers are navigating higher expectations for ingredient traceability, quality consistency, regulatory documentation, and responsible sourcing. The competitive landscape increasingly favors suppliers and formulators that combine validated efficacy, compliant claims, formulation compatibility, and transparent supply chains. Transformative Shifts in the Niacinamide Landscape

The niacinamide landscape is being reshaped by a shift from trend-led ingredient adoption to evidence-led, function-specific product development. In beauty and personal care, niacinamide has moved from a supporting vitamin ingredient to a hero active in serums, moisturizers, sunscreens, cleansers, scalp care, and body care, driven by consumer preference for barrier repair, tone correction, and sensitive-skin compatibility. Formulators are increasingly pairing niacinamide with hyaluronic acid, ceramides, zinc, panthenol, peptides, retinoids, and sunscreen actives, requiring careful attention to pH, stability, sensory performance, and claim substantiation. In nutraceuticals and pharmaceuticals, the focus is shifting toward dosage accuracy, regulatory-grade documentation, and differentiated delivery formats such as tablets, capsules, powders, and fortified products. In animal nutrition, niacinamide remains relevant due to its role in metabolism and feed fortification, particularly where livestock productivity and nutrient optimization are priorities. Sustainability is also changing procurement decisions, with buyers emphasizing supplier audits, impurity controls, lifecycle transparency, and compliance with regional chemical, food, cosmetic, and feed regulations. These shifts are elevating the importance of technical service, application testing, and documentation readiness across the value chain.

Cumulative Impact of Artificial Intelligence on Niacinamide Innovation

Artificial intelligence is accelerating the niacinamide value chain by improving formulation design, quality control, regulatory intelligence, and demand sensing without replacing the need for validated laboratory and clinical evidence. In product development, AI-enabled models can screen ingredient combinations, predict stability risks, evaluate texture outcomes, and help optimize niacinamide concentrations for specific positioning such as sensitive skin, blemish care, brightening, barrier repair, or wellness supplementation. In manufacturing, machine learning supports process monitoring, batch consistency, impurity detection, and deviation analysis, helping producers maintain tighter quality parameters for cosmetic, food, pharmaceutical, and feed-grade niacinamide. In regulatory and claims management, AI tools can monitor changes in ingredient rules, labeling requirements, permissible claims, and safety documentation across jurisdictions. In commercial execution, natural language processing and social listening help identify emerging consumer concerns, including skin barrier damage, hyperpigmentation, acne-prone routines, and ingredient minimalism. However, AI-generated insights must be governed by strong data quality standards, human scientific review, cybersecurity controls, and documented validation protocols. The most valuable impact of AI is its ability to shorten development cycles, reduce formulation rework, and strengthen evidence-based decision-making across niacinamide applications.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is a major center of niacinamide consumption and production activity, supported by large personal care, dietary supplement, pharmaceutical, and animal nutrition industries. China and India are especially important due to chemical manufacturing capabilities, expanding middle-class consumer bases, and demand for affordable functional ingredients, while Japan, South Korea, and Australia emphasize high-quality cosmetic formulations, regulatory discipline, and skin health innovation. North America is characterized by strong demand for dermatologist-supported skin care, dietary supplements, fortified foods, and clinically positioned wellness products, with the United States and Canada placing high importance on claims substantiation, ingredient safety, and transparent labeling. Latin America is gaining relevance through rising beauty and personal care consumption, increasing pharmacy retail penetration, and nutrition fortification initiatives, with Brazil and Mexico acting as key demand centers for skin care, hair care, and supplements. Europe reflects a highly regulated environment where cosmetic ingredient safety assessment, sustainability standards, and responsible claims are central to niacinamide commercialization; consumer preference for multifunctional yet gentle formulations supports continued use across facial care and body care. The Middle East is shaped by premium beauty adoption, sun exposure-related skin care needs, and demand for dermatology-aligned products, while Africa presents long-term opportunities tied to nutrition adequacy, pharmacy access, personal care expansion, and localized distribution strategies. Across all regions, regulatory alignment, quality documentation, and application-specific technical support remain decisive factors for market access.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO Economies

ASEAN markets are experiencing increasing niacinamide relevance as urban consumers adopt science-led skin care routines, halal-conscious formulations, and accessible beauty products across pharmacy, modern trade, and digital channels. The GCC shows strong affinity for premium personal care, dermatology-inspired products, and sun care-adjacent routines, making niacinamide attractive for formulations addressing uneven tone, barrier stress, and cosmetic resilience in hot climates. The European Union remains one of the most demanding regulatory environments for niacinamide-containing cosmetic, food, and health-related products, with compliance expectations around safety assessment, labeling, product information files, and evidence-based claims influencing both regional producers and exporters. BRICS countries collectively represent diverse demand drivers: China and India contribute scale in production and consumption, Brazil supports beauty and personal care uptake, Russia maintains pharmaceutical and nutrition demand, and South Africa provides a gateway to broader African distribution. G7 economies generally emphasize premiumization, clinical positioning, ingredient transparency, and high manufacturing standards, creating opportunities for differentiated niacinamide grades and documented efficacy. NATO member economies overlap significantly with advanced regulatory and quality systems in North America and Europe, where supply chain resilience, dual sourcing, and documentation reliability are increasingly important procurement considerations. Across these groups, success depends on adapting niacinamide positioning to local regulatory structures, purchasing power, consumer education levels, and product format preferences.

Key Country Insights for Niacinamide Adoption and Commercial Strategy

The United States is a leading demand environment for niacinamide in dermatologist-recommended skin care, acne-prone routines, barrier care, supplements, and fortified wellness products, supported by high consumer awareness and strong retail diversity. Canada reflects similar demand patterns with additional emphasis on bilingual labeling, safety documentation, and pharmacy-led skin health categories. Mexico combines growing beauty consumption with expanding access to personal care and supplement products, while Brazil stands out for its established cosmetics culture, body care adoption, and interest in multifunctional active ingredients suited to diverse climates and skin concerns. The United Kingdom remains influential in ingredient education, clinical skin care communication, and online beauty retail, while Germany prioritizes quality, tolerability, sustainability, and pharmacy-backed formulations. France combines dermocosmetic credibility with premium skin care demand, and Italy and Spain support niacinamide use through beauty, sun care, and personal care categories shaped by Mediterranean skin care routines. Russia maintains demand across pharmaceuticals, supplements, and personal care despite changing trade and supply conditions. China is central to niacinamide due to its manufacturing base, e-commerce-led beauty ecosystem, and strong consumer interest in brightening and blemish-care formulations. India is expanding through pharmaceuticals, nutraceuticals, affordable skin care, and a large youth consumer base, while Japan emphasizes high-purity, gentle, and technically refined formulations. Australia supports niacinamide use in sun-exposed skin care routines and regulated wellness channels, and South Korea continues to influence global product innovation through K-beauty formats, layered routines, and active ingredient education. Across these countries, the ability to align formulation claims with local regulations and consumer expectations is critical.

Actionable Recommendations for Niacinamide Industry Leaders

Industry leaders should prioritize evidence-based differentiation by linking niacinamide grades, concentrations, and product formats to specific, substantiated benefits such as barrier support, visible tone improvement, oil-control support, nutritional adequacy, or metabolic support. Formulators should invest in stability testing, compatibility screening, and sensory optimization, particularly when niacinamide is paired with retinoids, acids, peptides, zinc salts, ceramides, sunscreen filters, or botanical extracts. Suppliers should strengthen quality systems through impurity profiling, traceability documentation, batch-to-batch consistency, and audit-ready regulatory files for cosmetic, food, pharmaceutical, and feed applications. Brands should avoid overextended claims and instead develop compliant, localized messaging supported by clinical, instrumental, or literature-based evidence. Procurement teams should reduce supply risk by qualifying multiple sources, monitoring geopolitical and logistics disruptions, and assessing sustainability credentials. Digital teams should use AI-supported consumer intelligence to identify unmet needs, but scientific and regulatory teams must validate insights before claims are deployed. Companies competing in premium categories should emphasize transparency, skin compatibility, dermatologist alignment, and inclusive testing across skin types, while value-focused players should prioritize affordability, efficacy, and accessible education. The strongest strategies will integrate technical validation, regulatory readiness, responsible sourcing, and clear consumer communication.

Research Methodology for Evidence-Based Niacinamide Analysis

This executive summary is built from a structured secondary research approach using verified scientific, regulatory, and industry-relevant sources. The methodology includes review of peer-reviewed dermatology, nutrition, pharmaceutical, and cosmetic science literature covering niacinamide safety, efficacy, formulation behavior, and biological functions. Regulatory analysis considers publicly available guidance and frameworks from recognized authorities governing cosmetics, dietary supplements, pharmaceuticals, food fortification, chemical safety, and animal feed across major jurisdictions. Trade and industry interpretation is based on documented application trends, ingredient use patterns, product positioning, supply chain considerations, and regional regulatory requirements. Insights were synthesized through cross-validation of source credibility, consistency of evidence, and relevance to commercial decision-making. No market sizing, market share, or forecasting assumptions were applied. The analysis emphasizes data-backed qualitative intelligence, including application dynamics, regional adoption factors, technology impact, compliance considerations, and strategic implications for stakeholders across the niacinamide value chain.

Conclusion: Niacinamide Remains a Strategic Ingredient for Science-Led Product Innovation

Niacinamide is positioned as a high-utility ingredient supported by scientific credibility, broad formulation compatibility, and relevance across beauty, wellness, pharmaceutical, and nutrition applications. Its appeal is strongest where consumers and professionals seek multifunctional performance, tolerability, and clear evidence behind product claims. Regional dynamics show that Asia-Pacific contributes manufacturing depth and innovation momentum, North America and Europe drive high standards for claims and quality, Latin America and the Middle East support expanding beauty and wellness adoption, and Africa offers emerging opportunities linked to nutrition and personal care access. AI is adding value by improving development speed, quality consistency, regulatory monitoring, and consumer insight generation, but validated science and compliant documentation remain essential. For industry participants, the key to long-term success lies in combining high-quality niacinamide sourcing, application-specific efficacy support, responsible claims, and resilient supply chains. As ingredient transparency and science-led purchasing decisions continue to gain importance, niacinamide remains a cornerstone active for manufacturers and brands seeking credible, multifunctional solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Niacinamide Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablets
  • 7.6. Granules

8. Niacinamide Market, by Source

  • 8.1. Introduction
  • 8.2. Natural
    • 8.2.1. Plant Derived
    • 8.2.2. Fermentation Derived
  • 8.3. Synthetic

9. Niacinamide Market, by Purity Level

  • 9.1. Introduction
  • 9.2. Below 98%
  • 9.3. 98% to 99%
  • 9.4. Above 99%

10. Niacinamide Market, by Packaging Type

  • 10.1. Introduction
  • 10.2. Bottles
  • 10.3. Sachets
  • 10.4. Tubes
  • 10.5. Pouches

11. Niacinamide Market, by Application

  • 11.1. Introduction
  • 11.2. Animal Feed
    • 11.2.1. Aquaculture Feed
    • 11.2.2. Poultry Feed
    • 11.2.3. Swine Feed
  • 11.3. Cosmetics & Personal Care
    • 11.3.1. Color Cosmetics
    • 11.3.2. Hair Care
      • 11.3.2.1. Shampoos
      • 11.3.2.2. Conditioners
    • 11.3.3. Skin Care
      • 11.3.3.1. Serums
      • 11.3.3.2. Creams
      • 11.3.3.3. Lotions
      • 11.3.3.4. Face Masks
      • 11.3.3.5. Sunscreens
  • 11.4. Nutraceuticals & Dietary Supplements
  • 11.5. Food & Beverages
    • 11.5.1. Bakery Products
    • 11.5.2. Sports Nutrition
    • 11.5.3. Dairy Products
  • 11.6. Pharmaceuticals
    • 11.6.1. Dermatology Drugs
    • 11.6.2. Vitamin Deficiency Treatment
    • 11.6.3. Diabetes Management

12. Niacinamide Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Online
    • 12.2.1. Company Website
    • 12.2.2. eCommerce Platforms
  • 12.3. Offline
    • 12.3.1. Pharmacies & Drugstores
    • 12.3.2. Specialty Stores
    • 12.3.3. Supermarkets & Hypermarkets

13. Niacinamide Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Niacinamide Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Niacinamide Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aarti Drugs Limited
  • 17.2. Anhui Redpont Biotechnology Co., Ltd.
  • 17.3. Brother Enterprises Holding Co., Ltd.
  • 17.4. Crevil Cosmetics & Pharmaceuticals Germany GmbH
  • 17.5. CSPC Pharmaceutical Group Limited
  • 17.6. Evonik Industries AG
  • 17.7. Fagron NV
  • 17.8. Fengchen Group Co.,Ltd
  • 17.9. Foodchem International Corporation
  • 17.10. Glanbia Nutritionals, Inc.
  • 17.11. HCP Wellness
  • 17.12. Jubilant Ingrevia Limited
  • 17.13. Koninklijke DSM N.V.
  • 17.14. Lasons India Private Limited
  • 17.15. Lonza Group AG
  • 17.16. Merck KGaA
  • 17.17. Nutraceutical Corporation
  • 17.18. Prinova Group LLC
  • 17.19. Shandong Hongda Biotechnology Co., Ltd.
  • 17.20. Suzhou Springchem International Co., Ltd.
  • 17.21. Swadesh India Chemical Pvt Ltd
  • 17.22. Tianjin Zhongrui Pharmaceutical Co., Ltd.
  • 17.23. Triveni Interchem Pvt Ltd
  • 17.24. Western Drugs Ltd
  • 17.25. Zancheng Life Sciences Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NIACINAMIDE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NIACINAMIDE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POWDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POWDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GRANULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NATURAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NATURAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NATURAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLANT DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BELOW 98% MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BELOW 98% MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BELOW 98% MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 98% TO 99% MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 98% TO 99% MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 98% TO 99% MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABOVE 99% MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABOVE 99% MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABOVE 99% MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BOTTLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BOTTLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BOTTLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SACHETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SACHETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SACHETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POUCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POUCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POUCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AQUACULTURE FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AQUACULTURE FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AQUACULTURE FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POULTRY FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POULTRY FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POULTRY FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SWINE FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SWINE FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SWINE FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COSMETICS & PERSONAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COSMETICS & PERSONAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COSMETICS & PERSONAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COLOR COSMETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COLOR COSMETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COLOR COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HAIR CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HAIR CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HAIR CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHAMPOOS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SHAMPOOS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHAMPOOS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONDITIONERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONDITIONERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONDITIONERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SKIN CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SKIN CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SKIN CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SERUMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SERUMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SERUMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL LOTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LOTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LOTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FACE MASKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FACE MASKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FACE MASKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SUNSCREENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUNSCREENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SUNSCREENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUTRACEUTICALS & DIETARY SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NUTRACEUTICALS & DIETARY SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUTRACEUTICALS & DIETARY SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOOD & BEVERAGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOD & BEVERAGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FOOD & BEVERAGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BAKERY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BAKERY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BAKERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SPORTS NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SPORTS NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SPORTS NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DAIRY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DAIRY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DAIRY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VITAMIN DEFICIENCY TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VITAMIN DEFICIENCY TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VITAMIN DEFICIENCY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL COMPANY WEBSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANY WEBSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPANY WEBSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACIES & DRUGSTORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACIES & DRUGSTORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACIES & DRUGSTORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SPECIALTY STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SPECIALTY STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SPECIALTY STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUPERMARKETS & HYPERMARKETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SUPERMARKETS & HYPERMARKETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUPERMARKETS & HYPERMARKETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. GCC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 266. GCC NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 268. GCC NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 269. GCC NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. GCC NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 272. GCC NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. GCC NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 279. GCC NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 312. G7 NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 313. G7 NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 314. G7 NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 315. G7 NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 316. G7 NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 317. G7 NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. G7 NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 320. G7 NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 321. G7 NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 322. G7 NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 323. G7 NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. G7 NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 327. G7 NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 328. NATO NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 329. NATO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 330. NATO NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 331. NATO NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 332. NATO NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 333. NATO NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. NATO NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 336. NATO NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 337. NATO NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 338. NATO NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 339. NATO NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 340. NATO NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. NATO NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 343. NATO NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 344. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 361. CANADA NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 362. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 363. CANADA NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 364. CANADA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 365. CANADA NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 366. CANADA NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 367. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 368. CANADA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 369. CANADA NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 370. CANADA NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 371. CANADA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 372. CANADA NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 373. CANADA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 374. CANADA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 375. CANADA NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 376. CANADA NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 377. MEXICO NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 378. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 379. MEXICO NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 380. MEXICO NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 381. MEXICO NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 382. MEXICO NIACINAMIDE MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 383. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 384. MEXICO NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 385. MEXICO NIACINAMIDE MARKET SIZE, BY COSMETICS & PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 386. MEXICO NIACINAMIDE MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 387. MEXICO NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 388. MEXICO NIACINAMIDE MARKET SIZE, BY FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 389. MEXICO NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 390. MEXICO NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 391. MEXICO NIACINAMIDE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 392. MEXICO NIACINAMIDE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 393. BRAZIL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 394. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 395. BRAZIL NIACINAMIDE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 396. BRAZIL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 397. BRAZIL NIACINAMIDE MARKET SIZE, BY PURITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 398. BRAZIL NIACINAMI